Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- PMID: 34167641
- PMCID: PMC9090513
- DOI: 10.1016/j.jacc.2021.04.050
Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
Abstract
Background: Limited U.S. data exist regarding high-sensitivity cardiac troponin (cTn) implementation.
Objectives: This study sought to evaluate the impact of high-sensitivity cardiac troponin T (cTnT) implementation.
Methods: Observational U.S. cohort study of emergency department (ED) patients undergoing measurement of cTnT during the transition from 4th (pre-implementation March 12, 2018, to September 11, 2018) to 5th generation (Gen) cTnT (post-implementation September 12, 2018, to March 11, 2019). Diagnoses were adjudicated following the Fourth Universal Definition of Myocardial Infarction (MI). Resources evaluated included length of stay, hospitalizations, and cardiac testing.
Results: In this study, 3,536 unique patients were evaluated, including 2,069 and 2,491 ED encounters pre- and post-implementation. Compared with 4th Gen cTnT, encounters with ≥1 cTnT >99th percentile increased using 5th Gen cTnT (15% vs. 47%; p < 0.0001). Acute MI (3.3% vs. 8.1%; p < 0.0001) and myocardial injury (11% vs. 38%; p < 0.0001) increased. Although type 1 MIs increased (1.7% vs. 2.9%; p = 0.0097), the overall MI increase was largely due to more type 2 MIs (1.6% vs. 5.2%; p < 0.0001). Women were less likely than men to have MI using 4th Gen cTnT (2.3% vs. 4.4%; p = 0.008) but not 5th Gen cTnT (7.7% vs. 8.5%; p = 0.46). Overall length of stay and stress testing were reduced, and angiography was increased (all p < 0.05). Among those without cTnT increases, there were more ED discharges and a reduction in length of stay, echocardiography, and stress tests (all p < 0.05).
Conclusions: High-sensitivity cTnT implementation resulted in a marked increase in myocardial injury and MI, particularly in women and patients with type 2 MI. Despite this, except for angiography, overall resource use did not increase. Among those without cTnT increases, there were more ED discharges and fewer cardiac tests.
Keywords: cardiac troponin; myocardial infarction; myocardial injury; resource utilization.
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures This publication was made possible in part by the Mayo Clinic CTSA through grant UL1TR002377 from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health. Dr. Jaffe has consulted or presently consults for most of the major diagnostics companies, including Beckman, Abbott, Siemens, ET Healthcare, Roche, Radiometer, Sphingotec, Amgen, and Novartis. Dr. Sandoval has previously served on the Advisory Boards for Roche Diagnostics and Abbott Diagnostics without personal compensation; and has also been a speaker without personal financial compensation for Abbott Diagnostics. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment in
-
Downstream Consequences of Implementing High-Sensitivity Cardiac Troponin: Why Indication and Education Matter.J Am Coll Cardiol. 2021 Jun 29;77(25):3180-3183. doi: 10.1016/j.jacc.2021.04.063. Epub 2021 May 3. J Am Coll Cardiol. 2021. PMID: 33957240 Free PMC article. No abstract available.
-
Applying High-Sensitivity Cardiac Troponin T.J Am Coll Cardiol. 2021 Nov 2;78(18):e147. doi: 10.1016/j.jacc.2021.07.060. J Am Coll Cardiol. 2021. PMID: 34711344 No abstract available.
-
Reply: Applying High-Sensitivity Cardiac Troponin T.J Am Coll Cardiol. 2021 Nov 2;78(18):e149-e150. doi: 10.1016/j.jacc.2021.08.042. J Am Coll Cardiol. 2021. PMID: 34711345 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
